Literature DB >> 32518592

A chromosome 1q22 microdeletion including ASH1L is associated with intellectual disability in a Chinese family.

Hui Xi1,2, Ying Peng1,2, Wanqin Xie1, Jialun Pang1,2, Na Ma1,2, Shuting Yang1,2, Jinping Peng3, Hua Wang1,2.   

Abstract

BACKGROUND: Copy number variants (CNVs) associated with developmental delay and intellectual disability (DD/ID) continue to be identified in patients. This article reports identification of a chromosome 1q22 microdeletion as the genetic cause in a Chinese family affected by ID. CASE
PRESENTATION: The proband was a 19-year-old pregnant woman referred for genetic counseling and prenatal diagnosis at 18 weeks of gestation. She had severe ID with basically normal stature (height 154 cm [0 SD], weight 61 kg [- 0.2 SD], and head circumference 54 cm [- 1.12 SD]). Her distinctive facial features included a prominent forehead; flat face; flat nasal bridge and a short upturned nose; thin lips; and small ears. The proband's father was reported to have low intelligence, whereas her mother was of normal intelligence but with scoliosis. Chromosome microarray analysis (CMA) reveals that the proband, her father and the fetus all carry a 1q22 microdeletion of 936.3 Kb (arr[GRCh37] 1q22 (155016052_155952375)×1), which was not observed in her mother and paternal grandparents and uncles, suggesting a de novo mutation in the proband's father. The microdeletion involves 24 OMIM genes including ASH1L (also known as KMT2H and encoding a histone lysine methyltransferase). Of note, haploinsufficiency of ASH1L has been shown to be associated with neurodevelopmental disorders. Based on the inheritance of the detected CNV in the pedigree and similar CNVs associated with ID in public databases (Decipher, DGV and ClinVar) and literature, the detected CNV is considered as pathogenic. The family chose to terminate the pregnancy.
CONCLUSIONS: The identified 1q22 microdeletion including ASH1L is pathogenic and associated with ID. This case broadens the spectrum of ID-related CNVs and may be useful as a reference for clinicians.
© The Author(s) 2020.

Entities:  

Keywords:  1q22; ASH1L; Intellectual disability; Microdeletion; Prenatal diagnosis

Year:  2020        PMID: 32518592      PMCID: PMC7273683          DOI: 10.1186/s13039-020-00483-5

Source DB:  PubMed          Journal:  Mol Cytogenet        ISSN: 1755-8166            Impact factor:   2.009


Background

DD/ID refers to a large group of developmental disorders characterized by significant limitations in intellectual functioning and adaptive behaviors [1]. The onset of DD/ID usually is observed before the age of 18 years. Patients at the age of 5 years or younger who present with reasoning and learning difficulties and motor developmental delay are diagnosed as DD, whereas those who become symptomatic at the age over 5 years are regarded as ID [2]. DD/ID, with an estimated incidence of 1–3%, can be highly heterogeneous in clinical phenotype and genetic etiology [2]. About 25–50% DD/ID is associated with genetic alteration, such as 21, 18, or 13 trisomy or submicroscopic deletion/duplication [3]. CMA is featured by whole genome coverage, high resolution and rapid detection [4]. It has been recommended as the first-line clinical diagnostic test for individuals with unexplained DD/ID, autism spectrum disorders (ASDs) or multiple congenital anomalies (MCA) [5]. CMA can not only detect submicroscopic chromosomal imbalances, but also delineate the size and gene content of the detected segment. This is crucial for phenotype/genotype correlation and for identifying candidate genes involved in the development of certain anomalies [6]. The present case documented the clinical phenotype and genetic analysis of a Chinese family affected by ID using CMA.

Case presentation

The proband was a 19-year-old pregnant woman who was referred to the department of medical genetics at the hospital for prenatal diagnosis due to a family history of intellectual disability. She was delivered vaginally at full-term. During the neonatal period, she was hypotonic and very passive. Her growth milestones were recalled. She walked at 1 year and 8 months of age, and learned to say “mama” at 2 years. She talked at nearly 3 years and showed severe ID. She began the first period of menstrual at the age of 13 years, and got married at 18 years. She was in pregnancy at 18 weeks’ gestation when referred for genetic counseling and prenatal diagnosis. She had facial dysmorphism including a prominent forehead; flat face; flat nasal bridge and a short upturned nose; thin lips; and small ears (Fig. 1). Examinations in psychological clinic showed that her height was 154 cm [0 SD]; weight was 61 kg [− 0.2 SD]; and head circumference was 54 cm [− 1.12 SD] [7, 8]. Her IQ score was 32 as accessed by the Wechsler Adult Intelligence Scale-Revised China (WAIS-RC). In terms of the scale, a score ≤ 75 is considered as low intelligence, and a score of 32 suggests severe ID. Reportedly, she was able to care for herself in daily life. Clinical observation showed that she was introverted; seldom talked; had dementia and social dysfunction without depression and anxiety. Both her electroencephalogram (EEG) and brain MRI result were normal. No history of heart diseases was noted. Her father was reported to have low intelligence, but an on-site examination for her father was not achieved. Her mother was of normal intelligence but had scoliosis. Her paternal grandparents and uncles and the fetus’ father had no noticeable congenital anomalies.
Fig. 1

The pedigree (a) of a Chinese family affected by intellectual disability and facial features of the proband (b). The facial features of the proband (III-1) included a prominent forehead; flat face; flat nasal bridge and a short upturned nose; thin lips; and small ears

The pedigree (a) of a Chinese family affected by intellectual disability and facial features of the proband (b). The facial features of the proband (III-1) included a prominent forehead; flat face; flat nasal bridge and a short upturned nose; thin lips; and small ears Written informed consent was obtained from the family (The proband was under the guardianship of her mother). Peripheral blood for each participant and the amniotic fluid of the proband were drawn for genetic testing. Heart rate, blood pressure and electrocardiogram of the proband were monitored before amniocentesis. Conventional G-banded karyotype analysis showed a normal female karyotype (46,XX) in the proband. However, CMA using the CytoScan 750 K Array from Affymetrix (Thermo Fisher Scientific, USA) revealed a 936.3 kb heterozygous deletion of chromosome 1q22 (arr[GRCh37] 1q22 (155016052_155952375)×1) in the proband (Fig. 2). The microdeletion was also detected in the proband’s father (II-2) and the fetus (IV-1), but absent in her mother (II-1), grandparents (I-1, I-2) and paternal uncles (II-3, II-4). Other members within the pedigree were not tested. For all tested individuals, no other CNVs were detected except known polymorphisms (frequency > 1%).
Fig. 2

The SNP-array results of tested members from the Chinese family affected by intellectual disability. The proband (III-1), her father (II-2) and the fetus (IV-1) all contain a 936.3 kb heterozygous deletion of chromosome 1q22 (arr[GRCh37] 1q22 (155016052_155952375)×1). No significant CNVs were identified in the proband’s mother (II-1), grandparents (I-1 and -2) and paternal uncle II-3

The SNP-array results of tested members from the Chinese family affected by intellectual disability. The proband (III-1), her father (II-2) and the fetus (IV-1) all contain a 936.3 kb heterozygous deletion of chromosome 1q22 (arr[GRCh37] 1q22 (155016052_155952375)×1). No significant CNVs were identified in the proband’s mother (II-1), grandparents (I-1 and -2) and paternal uncle II-3 In search of public databases (Decipher, DGV and ClinVar) and literature, a few cases reported copy number losses of the 1q22 region including ASH1L and the associated phenotypes including ID with MCA (Table 1). Furthermore, haploinsufficiency of ASH1L is strongly associated with DD/ID and MCA in multiple individual cases [9, 10]. On the basis of these observations, plus the co-segregation of genotype and phenotype in the current case, the detected CNV is considered to be pathogenic, being in line with the guidelines from the American College of Medical Genetics (ACMG) [11]. After full consideration, the family chose to terminate the pregnancy.
Table 1

1q22 microdeletions/duplications including ASH1L from public databases and literature

Database/ LiteratureIndex IDVariantSizeInheritancePhenotype(s)Clinic Significance
This report/

[GRCh37] 1q22 (155016052

_155952375)×1

936.3 KbPaternalIntellectual disability, behavioral problems, forehead, flat face, flat nasal bridge, short upturned nose, thin lips, small ears.Pathogenic
Faundes et al.*/

[GRCh37] 1q22 (155271366

_155804269)×1

532.9 KbDe novoIntellectual disability, behavioral problems, cryptorchidism and blocked nasolacrimal duct, microcephaly,/
Decipher249,031

[GRCh37] 1q22 (154292095

−155569326)×1

1.28 MbDe novoDelayed speech and language development, hypertelorism, intellectual disability, long face, low-set earsUnknown
Decipher255,240

[GRCh37] 1q22 (155192986

_156108069)×1

915.08 KbUnknownBroad nasal tip, delayed speech and language development, dental malocclusion, intellectual disability, low-set ears, malar flattening, narrow palate, nasal speech, posteriorly rotated earsUnknown
Decipher359,103

[GRCh37] 1q22 (154687479

_156014014)×1

1.33 MbDe novoAbnormality of the nervous system, autism, scoliosis

Likely

pathogenic

DGVesv33869

[GRCh37] 1q22 (155223283

_155917961)×1

694.6Kb///
DGVdgv3n68

[GRCh37] 1q22 (155094978

_155313409)×1

218.4 Kb///
ClinVarVCV000659609.1

[GRCh37] 1q22 (155294636

_155452240)×1

157.6Kb//Pathogenic
Decipher251,442

[GRCh37] 1q22 (155264908

_156495512)×3

1.23 MbInheritedCryptorchidism, delayed speech and language development, intellectual disability, strabismusUnknown
ClinVarVCV000253835.1

[GRCh37] 1q22 (155412745

_155755215)×3

342.47 kb/Attention deficit hyperactivity disorderUncertain

Selected deletion/duplication cases are listed. “/”, information not provided; “*”, reference [9]

1q22 microdeletions/duplications including ASH1L from public databases and literature [GRCh37] 1q22 (155016052 _155952375)×1 [GRCh37] 1q22 (155271366 _155804269)×1 [GRCh37] 1q22 (154292095 −155569326)×1 [GRCh37] 1q22 (155192986 _156108069)×1 [GRCh37] 1q22 (154687479 _156014014)×1 Likely pathogenic [GRCh37] 1q22 (155223283 _155917961)×1 [GRCh37] 1q22 (155094978 _155313409)×1 [GRCh37] 1q22 (155294636 _155452240)×1 [GRCh37] 1q22 (155264908 _156495512)×3 [GRCh37] 1q22 (155412745 _155755215)×3 Selected deletion/duplication cases are listed. “/”, information not provided; “*”, reference [9]

Discussion

The identified microdeletion in the proband involves 43 known genes, of which 24 were OMIM genes, including ADAM15 (OMIM: 605548), EFNA4 (OMIM: 601380), EFNA3 (OMIM: 601381), EFNA1 (OMIM: 191164), SLC50A1 (OMIM: 613683), DPM3 (OMIM: 605951), TRIM46 (OMIM: 600986), MUC1 (OMIM: 158340), THBS3 (OMIM: 188062), MTX1 (OMIM: 600605), GBA (OMIM: 606463), SCAMP3(OMIM: 606913), CLK2 (OMIM: 602989), HCN3(OMIM: 609973), PKLR (OMIM: 609712), FDPS (OMIM: 134629), ASH1L (OMIM: 607999), YY1AP1 (OMIM: 607860), DAP3 (OMIM: 602074), GON4L (OMIM: 610393), SYT11 (OMIM: 608741), RIT1 (OMIM: 609591), RXFP4 (OMIM: 609043), and ARHGEF2 (OMIM: 607560). Among these OMIM genes, TRIM46, CLK2, ASH1L, GON4L and ARHGEF2 are marked by a high probability of being loss of function intolerant (pLI ≥ 0.9), in contrast to other genes with a moderate (RIT1 pLI: 0.67) or low probability. Therefore, haploinsufficiency of the genes with high pLI is particularly concerned. In OMIM database, the phenotypes of heterozygous loss of TRIM46, CLK2, GON4L and ARHGEF2 in humans have not been fully documented, whereas a handful of individual patients featured by intellectual disability are reported to carry a heterozygous nonsense or frame-shift mutation of ASH1L, which results in truncated and nonfunctional protein [12-14]. The documented cases highly support that alteration in gene dosage of ASH1L is associated with neurodevelopmental disorders. In more recent studies, additional de novo loss of function variants of ASH1L have been identified, and all patients presented with mild to severe DD/ID [10]. Interestingly, a 532.9 kb heterozygous deletion (arr[GRCh37] 1q22 (155271366_155804269)×1) was found in a 7-year-old boy who had microcephaly and severe ID with MCA [9, 10]. Notably, the microdeletion identified in the present case fully encompasses the 532.9 kb segment and involves more OMIM genes. Based on these observations, the 1q22 microdeletion of 936.3 Kb including ASH1L is regarded as pathogenic and associated with ID. Importantly, not only micro-deletions, but also duplications within 1q22 may cause neurodevelopmental abnormalities (Table 1). Though the pathogenicity of ASH1L haploinsufficiency is evident, contribution of other OMIM genes (e.g. CLK2, ARHGEF2 and RIT1) to the phenotypes in this case cannot be fully excluded [15-17]. It is noteworthy that some clinical features of the proband resemble certain phenotypes such as broad forehead, broad nasal bridge, and learning/intellectual disabilities described in Noonan syndrome (NS), an autosomal-dominant disorder [15]. In a more recent report on the molecular and phenotypic spectrum of a Chinese NS cohort (n = 103), 6 out of 7 patients with RIT1 mutation presented with various congenital heart defects, and a high rate (4 out of 7) of hypertrophic cardiomyopathy was observed in RIT1 mutation-positive patients [18]. With regard to the proband in this report, although cardiac imaging examination was not performed, heart rate, blood pressure and electrocardiogram were recorded prior to ultrasound-guided amniocentesis. The normal readouts plus no previous history of heart disease suggested that it was unlikely that the patient had cardiomyopathy. Taking the potential involvement of multiple functional genes into account, it remains to be further elucidated whether this 1q22 microdeletion causes contiguous gene syndrome. ASH1L encodes a histone lysine methyltransferase that catalyzes mono- and di-methylation of histone 3 lysine 36 (H3K36). This gene is highly expressed in both embryonic and adult human brains [19]. An inadequate amount of ASH1L protein due to copy number loss of the gene may affect epigenetic regulation of the expression program involved in embryo and brain development. Animal model studies show that mice in homozygosity of a hypomorphic ASH1L allele exhibited growth insufficiency, skeletal transformations and impaired fertility associated with developmental defects of reproductive organs [20]. In this case, the 1q22 microdeletion including ASH1L resulted from a de novo mutation in the proband‘s father. Phenotipically, both the proband and her father were fertile, suggesting that haploinsufficiency of ASH1L may not cause infertility in humans. In summary, the present case shows the clinical phenotype of the proband in a Chinese family affected by ID and identification of a 1q22 microdeletion including ASH1L as the genetic cause in the pedigree. This case broadens the spectrum of ID-related CNVs and may be useful as a reference for clinicians. Apart from clinical findings, certain social and ethic issues also are brought into our sight by the case. For instance, was the pregnancy of the proband’s own free will? How should the fate of the fetus be decided? Though it may take time to find out the best solutions for the scenario resembling the case, there is no doubt that more social care is demanded with regard to women patients with intellectual disability.
  18 in total

1.  Functional hemizygosity of PAFAH1B3 due to a PAFAH1B3-CLK2 fusion gene in a female with mental retardation, ataxia and atrophy of the brain.

Authors:  H G Nothwang; H G Kim; J Aoki; M Geisterfer; S Kübart; R D Wegner; A van Moers; L K Ashworth; T Haaf; J Bell; H Arai; N Tommerup; H H Ropers; J Wirth
Journal:  Hum Mol Genet       Date:  2001-04-01       Impact factor: 6.150

2.  Molecular and phenotypic spectrum of Noonan syndrome in Chinese patients.

Authors:  Xin Li; Ruen Yao; Xin Tan; Niu Li; Yu Ding; Juan Li; Guoying Chang; Yao Chen; Lizhuang Ma; Jian Wang; Lijun Fu; Xiumin Wang
Journal:  Clin Genet       Date:  2019-07-10       Impact factor: 4.438

Review 3.  A clinical approach to developmental delay and intellectual disability.

Authors:  Pradeep Vasudevan; Mohnish Suri
Journal:  Clin Med (Lond)       Date:  2017-12       Impact factor: 2.659

Review 4.  Prenatal diagnosis by chromosomal microarray analysis.

Authors:  Brynn Levy; Ronald Wapner
Journal:  Fertil Steril       Date:  2018-02       Impact factor: 7.329

Review 5.  Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.

Authors:  David T Miller; Margaret P Adam; Swaroop Aradhya; Leslie G Biesecker; Arthur R Brothman; Nigel P Carter; Deanna M Church; John A Crolla; Evan E Eichler; Charles J Epstein; W Andrew Faucett; Lars Feuk; Jan M Friedman; Ada Hamosh; Laird Jackson; Erin B Kaminsky; Klaas Kok; Ian D Krantz; Robert M Kuhn; Charles Lee; James M Ostell; Carla Rosenberg; Stephen W Scherer; Nancy B Spinner; Dimitri J Stavropoulos; James H Tepperberg; Erik C Thorland; Joris R Vermeesch; Darrel J Waggoner; Michael S Watson; Christa Lese Martin; David H Ledbetter
Journal:  Am J Hum Genet       Date:  2010-05-14       Impact factor: 11.025

6.  Diagnostic exome sequencing in persons with severe intellectual disability.

Authors:  Joep de Ligt; Marjolein H Willemsen; Bregje W M van Bon; Tjitske Kleefstra; Helger G Yntema; Thessa Kroes; Anneke T Vulto-van Silfhout; David A Koolen; Petra de Vries; Christian Gilissen; Marisol del Rosario; Alexander Hoischen; Hans Scheffer; Bert B A de Vries; Han G Brunner; Joris A Veltman; Lisenka E L M Vissers
Journal:  N Engl J Med       Date:  2012-10-03       Impact factor: 91.245

7.  De novo loss-of-function variants of ASH1L are associated with an emergent neurodevelopmental disorder.

Authors:  Wei Shen; Patti Krautscheid; Audrey M Rutz; Pinar Bayrak-Toydemir; Sarah L Dugan
Journal:  Eur J Med Genet       Date:  2018-05-22       Impact factor: 2.708

8.  Genotype and phenotype in patients with Noonan syndrome and a RIT1 mutation.

Authors:  Karim Kouz; Christina Lissewski; Stephanie Spranger; Diana Mitter; Angelika Riess; Vanesa Lopez-Gonzalez; Sabine Lüttgen; Hatip Aydin; Florian von Deimling; Christina Evers; Andreas Hahn; Maja Hempel; Ulrike Issa; Anne-Karin Kahlert; Adrian Lieb; Pablo Villavicencio-Lorini; Maria Juliana Ballesta-Martinez; Sheela Nampoothiri; Angela Ovens-Raeder; Alena Puchmajerová; Robin Satanovskij; Heide Seidel; Stephan Unkelbach; Bernhard Zabel; Kerstin Kutsche; Martin Zenker
Journal:  Genet Med       Date:  2016-04-21       Impact factor: 8.822

9.  New insights in the interpretation of array-CGH: autism spectrum disorder and positive family history for intellectual disability predict the detection of pathogenic variants.

Authors:  Gerarda Cappuccio; Francesco Vitiello; Alberto Casertano; Paolo Fontana; Rita Genesio; Dario Bruzzese; Virginia Maria Ginocchio; Angela Mormile; Lucio Nitsch; Generoso Andria; Daniela Melis
Journal:  Ital J Pediatr       Date:  2016-04-12       Impact factor: 2.638

10.  Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases.

Authors:  Holly A F Stessman; Bo Xiong; Bradley P Coe; Tianyun Wang; Kendra Hoekzema; Michaela Fenckova; Malin Kvarnung; Jennifer Gerdts; Sandy Trinh; Nele Cosemans; Laura Vives; Janice Lin; Tychele N Turner; Gijs Santen; Claudia Ruivenkamp; Marjolein Kriek; Arie van Haeringen; Emmelien Aten; Kathryn Friend; Jan Liebelt; Christopher Barnett; Eric Haan; Marie Shaw; Jozef Gecz; Britt-Marie Anderlid; Ann Nordgren; Anna Lindstrand; Charles Schwartz; R Frank Kooy; Geert Vandeweyer; Celine Helsmoortel; Corrado Romano; Antonino Alberti; Mirella Vinci; Emanuela Avola; Stefania Giusto; Eric Courchesne; Tiziano Pramparo; Karen Pierce; Srinivasa Nalabolu; David G Amaral; Ingrid E Scheffer; Martin B Delatycki; Paul J Lockhart; Fereydoun Hormozdiari; Benjamin Harich; Anna Castells-Nobau; Kun Xia; Hilde Peeters; Magnus Nordenskjöld; Annette Schenck; Raphael A Bernier; Evan E Eichler
Journal:  Nat Genet       Date:  2017-02-13       Impact factor: 38.330

View more
  4 in total

Review 1.  Structural and functional specificity of H3K36 methylation.

Authors:  Ulysses Tsz Fung Lam; Bryan Kok Yan Tan; John Jia Xin Poh; Ee Sin Chen
Journal:  Epigenetics Chromatin       Date:  2022-05-18       Impact factor: 5.465

2.  Vorinostat, a histone deacetylase inhibitor, ameliorates the sociability and cognitive memory in an Ash1L-deletion-induced ASD/ID mouse model.

Authors:  Yuen Gao; Mohammad B Aljazi; Yan Wu; Jin He
Journal:  Neurosci Lett       Date:  2021-09-10       Impact factor: 3.046

3.  Neural Hyperactivity Is a Core Pathophysiological Change Induced by Deletion of a High Autism Risk Gene Ash1L in the Mouse Brain.

Authors:  Yuen Gao; Mohammad B Aljazi; Jin He
Journal:  Front Behav Neurosci       Date:  2022-04-05       Impact factor: 3.558

4.  Loss of histone methyltransferase ASH1L in the developing mouse brain causes autistic-like behaviors.

Authors:  Yuen Gao; Natalia Duque-Wilckens; Mohammad B Aljazi; Yan Wu; Adam J Moeser; George I Mias; Alfred J Robison; Jin He
Journal:  Commun Biol       Date:  2021-06-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.